BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34296267)

  • 1. Cancers of Unknown Primary: A Descriptive Study in the U.S. Military Health System.
    Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
    Mil Med; 2023 Mar; 188(3-4):e516-e523. PubMed ID: 34296267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancers of unknown primary: Survival by histologic type, demographic features, and treatment in the U.S. Military Health System.
    Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
    Cancer Epidemiol; 2023 Feb; 82():102316. PubMed ID: 36571909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival among patients with glioma in the US Military Health System: A comparison with patients in the Surveillance, Epidemiology, and End Results program.
    Lin J; Bytnar JA; Theeler BJ; McGlynn KA; Shriver CD; Zhu K
    Cancer; 2020 Jul; 126(13):3053-3060. PubMed ID: 32286688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.
    Anderson AB; Kim E; Park AB; Zhu K; Lin J; Shriver CD; Potter BK
    J Am Acad Orthop Surg; 2024 Jul; 32(13):e651-e660. PubMed ID: 38684126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population.
    Lin J; Kamamia C; Brown D; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):673-679. PubMed ID: 29531129
    [No Abstract]   [Full Text] [Related]  

  • 6. Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population.
    Lin J; Nousome D; Jiang J; Chesnut GT; Shriver CD; Zhu K
    Br J Cancer; 2023 Apr; 128(6):1070-1076. PubMed ID: 36609596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Survival among Colon Cancer Patients in the U.S. Military Health System and Patients in the Surveillance, Epidemiology, and End Results (SEER) Program.
    Lin J; McGlynn KA; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1359-1365. PubMed ID: 34162655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
    Lin J; Hu H; Shriver CD; Zhu K
    Clin Breast Cancer; 2022 Jun; 22(4):e506-e516. PubMed ID: 34961733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Trends in the Distribution of Lung Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results data, 1989-2012.
    Nations JA; Brown DW; Shao S; Shriver CD; Zhu K
    Mil Med; 2020 Dec; 185(11-12):e2044-e2048. PubMed ID: 32857164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SEER) program.
    Lin J; Kamamia C; Brown DW; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
    Ann Epidemiol; 2021 Dec; 64():132-139. PubMed ID: 34547444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults.
    Pavlidis N; Rassy E; Smith-Gagen J
    Int J Cancer; 2020 Mar; 146(6):1490-1498. PubMed ID: 31144291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
    Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
    Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and therapeutic management of cancer of an unknown primary.
    Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
    Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
    Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
    Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in Pediatric, Adolescent, and Young Adult Patients With Sarcoma in the Military Health System: Comparison With the SEER Population.
    Vasta LM; Zanetti RC; Anderson AB; Zhu K; Potter BK; Park AB; Lin J; Shriver CD; Warwick AB
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e832-e840. PubMed ID: 34397617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities.
    Urban D; Rao A; Bressel M; Lawrence YR; Mileshkin L
    Br J Cancer; 2013 Sep; 109(5):1318-24. PubMed ID: 23860528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs).
    Pisacane A; Cascardi E; Berrino E; Polidori A; Sarotto I; Casorzo L; Panero M; Boccaccio C; Verginelli F; Benvenuti S; Dellino M; Comoglio P; Montemurro F; Geuna E; MarchiĆ² C; Sapino A
    Virchows Arch; 2023 Mar; 482(3):463-475. PubMed ID: 36346458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer incidence in the U.S. military population: comparison with rates from the SEER program.
    Zhu K; Devesa SS; Wu H; Zahm SH; Jatoi I; Anderson WF; Peoples GE; Maxwell LG; Granger E; Potter JF; McGlynn KA
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1740-5. PubMed ID: 19505907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma of unknown primary (CUP).
    Pavlidis N; Fizazi K
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.